• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Product News

Product News

PRODUCT CLI ELITECHGROUP

ELITechGroup’s Staining Technology Expands with Aerospray® Cytology Slide Stainer/Cytocentrifuge

, 26 August 2020/in Product News /by 3wmedia

Logan, UT, January 17, 2020 – ELITechGroup Inc., recognized worldwide as slide staining and cytocentrifuge technologic pioneers and innovators, with nearly 30 patents, over the 35-year lifespan of Aerospray staining technology, announces the launch of the Aerospray Cytology Slide Stainer Cytocentrifuge. The ELITechGroup’s Aerospray Cytology Slide Stainer/Cytocentrifuge automates the preparation and staining of liquid based cytology specimens to facilitate the examination of an array of cell differentiations utilizing Papanicolaou staining techniques. The advantages of the Aerospray Cytology Slide Stainer/Cytocentrifuge is that the device performs two functions of sample preparation through cytocentrifugation and sample staining. The system maximizes cell recovery to the slide through the use of its Cytopro® Rotor, eliminates cross-contamination with an application of fresh stain for each slide, and provides programmable regressive and progressive staining capabilities that can be stored in memory to meet the needs and preferences of any end user. The instrument standardizes staining across multiple labs, provides consistently high-quality control, is low maintenance, reduces the labor/cost per slide, enables laboratory compliance, and is the perfect back-up for high automation laboratories for specialty staining and during maintenance. “ELITechGroup’s portfolio of Aerospray slide stainers and cytocentrifuges has enabled the company to develop a worldwide reputation for performance and reliability. Our new Aerospray Cytology Stainer/Cytocentrifuge proves our commitment to ongoing innovation by expanding into new laboratories where we can offer superior staining results,” says Bryce McEuen, Vice President, Biomedical Systems. ELITechGroup will be showcasing the Aerospray Cytology Slide Stainer/Cytocentrifuge at key industry events throughout the year of 2020. Learn more at AerosprayStaining.com.
About ELITechGroup
ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents for clinical systems, microbiology, molecular diagnostics, hematology, cytology, and sweat test systems. Their mission is to improve patient care by empowering laboratories to do more in less time, with accuracy, to enable rapid and accurate course of treatment for patients.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/PRODUCT_CLI_ELITECHGROUP.jpg 286 638 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:38ELITechGroup’s Staining Technology Expands with Aerospray® Cytology Slide Stainer/Cytocentrifuge

GE Healthcare Life Sciences releases software for cell therapy workflow

, 26 August 2020/in Product News /by 3wmedia

GE Healthcare Life Sciences continues to build out its flexible solutions across the cell therapy workflow with the commercial availability of SpinOculation C-Pro Protocol Software. Part of the Sepax™ C-Pro Cell Processing System, the software closes and automates the cell transduction step. When used in combination with the Sepax C-Pro instrument and CT-60.1 single-use kit, the software enables users to choose the volume and cell concentration from initial cell preparation through transduction to final resuspension, without compromising cell viability and virus stability.
Catarina Flyborg, General Manager, Cell and Gene Therapy, GE Healthcare Life Sciences, said: “Cell therapy manufacturing is complex and requires advanced technologies.
The SpinOculation C-Pro software application automates and simplifies a critical step in the cell therapy workflow and helps accelerate the development of next generation therapeutics.” Additionally, the SpinOculation C-Pro Protocol helps users:

  • Gain reproducibility in transduction steps with an automated and closed solution
  • Save time in the manufacturing process by reducing manipulations
  • Optimize transduction performance by adjusting open system parameters
  • Simplify process validation by not using transduction enhancers

The SpinOculation C-Pro application software is available worldwide.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:39GE Healthcare Life Sciences releases software for cell therapy workflow
CLI TRIMERO EPN on July 4 2019

C1q, C1 Inhibitor, C5 and Factor B assays for nephelometry and turbidimetry

, 26 August 2020/in Product News /by 3wmedia

TRIMERO offers C1q, C5, C1 (Esterase) Inhibitor and Factor B (C3 Proactivator) CE- marked assays for nephelometry and turbidimetry.
Assays are available for IMMAGE® immunochemical systems of Beckman Coulter and for BN™ Series nephelometers of Siemens Healthineers.
Turbidimetric assays and applications are also available for the most popular clinical chemistry analysers.
In order to ensure lot to lot traceability, values ​​have been referred to the International Ref. Preparation for human serum complement Factors (NIBSC code: W1032) of the WHO (World Health Organization). 
Other available assays for nephelometry and turbidimetry include:
KLoneus® Free Light Chains (FLC), Serum Amyloid A (SAA), IgD Immunoglobulins, Retinol Binding Protein (RBP) for serum and urine, Soluble Transferrin Receptor (sTfR), Hemopexin, Cystatin-C for serum and urine, A1-Microglobulin, B2-Microglobulin for serum and urine, Kappa and Lambda Light Chains for serum and urine.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/CLI_TRIMERO_EPN_on_July_4__2019.png 353 402 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:49C1q, C1 Inhibitor, C5 and Factor B assays for nephelometry and turbidimetry
horizon discovery

Horizon Discovery extends coverage of OncoSpan reference standards to FFPE and Liquid Biopsy

, 26 August 2020/in Product News /by 3wmedia

Horizon Discovery Group, a global leader in the application of gene editing and gene modulation for cell line engineering, has added two new sample formats to its cell-based OncoSpan reference standards for use in the development and validation of workflows for cancer diagnostic assays.
Horizon’s OncoSpan range now includes formalin-fixed, paraffin-embedded (FFPE) and cell-free DNA (cfDNA) formats for mimicking solid tumors and liquid biopsy samples, respectively, in addition to its well-established genomic DNA (gDNA) format. Its cfDNA format offers one of the largest number of variants and genes, over 380 and 152 respectively, of any characterized reference standard to help standardize liquid biopsy testing.
These cell-line derived reference standards closely mimic patient samples and offer an unlimited and reproducible resource to help ensure consistency during the establishment and validation of diagnostic assays. All three formats are delivered with batch-specific, next-generation sequencing (NGS) data, orthogonally validated by ddPCR, to allow researchers to further validate their analysis pipeline.
For further information, visit: horizondiscovery.com/en/products/diagnostic-reference-standards/PIFs/OncoSpan-cfDNA
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/horizon_discovery-scaled.jpg 2560 2560 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:34Horizon Discovery extends coverage of OncoSpan reference standards to FFPE and Liquid Biopsy
logo integra biosciences

Pipette tips designed for Integra pipettes

, 26 August 2020/in Product News /by 3wmedia

INTEGRA Biosciences has developed its GripTip pipette tips range to overcome the problems associated with the use of universal pipette tips. Universal pipette tips require hammering on to stretch the tip, often resulting in a suboptimal fit that can lead to loose, leaking and falling off tips. GripTips are designed to offer a perfect fit on INTEGRA pipettes, effortlessly snapping onto the tip fittings with low attachment and ejection forces. This ensures that all tips are at the same height, guaranteeing perfect alignment and seal, even when performing side well touch-offs. They span a wide volume range – from 0.5 to 5000 µl – and are available in sterile,  non-sterile and filtered options. The portfolio also includes a number of specialty GripTips, such as low retention tips for recovering viscous solutions, wide bore tips for cellular applications, short tips for improved ergonomics and targeting of small wells, and extra long tips for improved access to tubes. This range is continuously being expanded to ensure that there are GripTips to meet the needs of every customer, for every application. The two latest tips include a 1250 µl short tip – perfect for ergonomically pipet-ting large volumes, by eliminating the need to hold the pipette high over the bench, reducing the risk of RSI – and a 300-µl long tip that, at 102 mm long, enables the user to easily reach the bottom of standard 100 ml tubes. To aid tip selection, INTEGRA has launched its GripTip selector, simply using filters to identify the most suitable tips for the required workflow in seconds.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/logo-integra_biosciences.jpg 170 600 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:44Pipette tips designed for Integra pipettes
C432 Abbott Alinity m

Infectious disease testing system and assays

, 26 August 2020/in Product News /by 3wmedia

Abbott has announced CE Mark for the Alinity m diagnostic system and assays that will allow laboratories to meet the growing demand for infectious disease testing by offering increased efficiency, speed and accuracy. This new technology will provide high flexibility in molecular diagnostic testing, allowing more tests to be done in shorter timeframes, while reducing the space and number of instruments needed to conduct large amounts of tests. The World Health Organization (WHO) reports that more than a billion people around the world are living with infectious diseases. For people living with infectious diseases, quick and accurate molecular test results are needed to help prevent the spread of communicable diseases globally. Advanced molecular testing also allows patients to be diagnosed correctly and then monitored for their response to treatment. Molecular laboratories are playing an increasingly important role in providing critical test results for infectious disease diagnosis. Alinity m will significantly improve the way these laboratories operate by letting staff run any sample at any time, without the need to group samples, allowing them to focus on giving physicians the information they need to make accurate, timely clinical decisions. Alinity m provides superior flexibility for lab staff and faster testing results for clinicians and patients.  Alinity m may also reduce the lab equipment footprint from four to six instruments down to one – decreasing the space requirements and hours spent learning and maintaining different instruments. Now available in countries that recognize CE Mark, Alinity m offers initial assays including virologic testing for human immunodeficiency virus type 1 (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV); sexual health-related testing for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium or CT/NG/TV/MG panel; and high-risk human papillomavirus (HPV) testing. Local product availability may vary depending on geographic location.

ABBOTT
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C432_Abbott_Alinity_m.jpg 569 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:52Infectious disease testing system and assays
amsbiopr271 01

AMSBIO introduces StemFit for Differentiation for human iPS and ES cells

, 26 August 2020/in Product News /by 3wmedia

AMSBIO has introduced StemFit for Differentiation – a new chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells.
The unique chemically defined composition of StemFit for Differentiation minimizes lot-to-lot variation, enabling highly consistent cell differentiation. Free of animal- and human-derived components, StemFit for Differentiation can be used to eliminate the risk of immunogenic contamination.
Applications proven to benefit from StemFit for Differentiation include: lineage-specific (endodermal, mesodermal and ectodermal) differentiation where this new product is used to replace serum-free supplements, as well as spontaneous differentiation of hiPSCs to organoids via embryoid body formation.
Used in combination with StemFit Basic feeder-free medium with iMatrix-511 laminin as extracellular matrix, StemFit for Differentiation enables researchers to undertake clinical applications involving both expansion and differentiation of human Pluripotent Stem Cell-derived cells and tissues.
Supplied as a 5X concentrate, StemFit for Differentiation has been formulated for use with basal cell culture medium (e.g. DMEM, RPMI 1640, DMEM/F12 etc.) and a variety of different induction factors or cytokines (including Activin A and bFGF from AMSBIO).

  • For further information on StemFit for Differentiation, visit: www.amsbio.com/stemfit-for-differentiation

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/amsbiopr271_01.jpg 808 808 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:29AMSBIO introduces StemFit for Differentiation for human iPS and ES cells
PRODUCT CLI MICROLUTE

Porvair Sciences sets a new standard for labs with Microlute Protein Precipitation Plate

, 26 August 2020/in Product News /by 3wmedia

Incorporating a novel dual hydrophobically treated matrix filter, Microlute Protein Precipitation Plate from Porvair Sciences sets a new standard for labs looking to remove interfering proteins from serum, plasma or whole blood samples prior to analysis by Liquid Chromatography / Mass Spectrometry (LC/MS). Biological samples commonly contain proteins that interfere with downstream applications such as LC/MS analysis. Microlute Protein Precipitation Plates (PPP) use the CRASH method, in which protein is denatured with acetonitrile and the flocculant filtered out, allowing 96 samples to be processed in parallel. Based on the industry standard MicroLute format, but without the chromatographic sorbent, protein ‘crashes’ out of solution and precipitates directly in each well when acetonitrile is added, thus solving all common problems associated with the CRASH technique of protein cleanup. The novel dual frit, hydrophobically treated matrix used by the Microlute PPP means that there is no ‘wetting out’ and leakage of sample before the application of vacuum. Due to its ease of use, high performance and reliability the Microlute PPP is commonly used as the protein precipitation plate of choice in many major pharmaceutical companies worldwide. Established in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/PRODUCT_CLI_MICROLUTE.jpg 457 694 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:37Porvair Sciences sets a new standard for labs with Microlute Protein Precipitation Plate
CLI 190902 doc Image SAA

Serum Amyloid A (SAA), CE-IVD marked, turbidimetric assay

, 26 August 2020/in Product News /by 3wmedia

TRIMERO has added to its catalogue a new Serum Amyloid A, CE-IVD marked, particle-enhanced turbidimetric immunoassay. Applications are available for the most popular clinical chemistry analysers, and for IMMAGE® nephelometers of Beckman Coulter. In order to ensure lot to lot traceability, the assay has been standardized to the Serum Amyloid A (SAA) 1st International Standard (NIBSC code: 92/680) of the WHO (World Health Organization).

Other available assays for turbidimetry and nephelometry include:

KLoneus® Free Light Chains (FLC), IgD Immunoglobulins, Retinol Binding Protein (RBP) for serum and urine, Soluble Transferrin Receptor (sTfR), Hemopexin, Cystatin-C for serum and urine, A1-Microglobulin, B2-Microglobulin for serum and urine, Kappa and Lambda Light Chains for serum and urine, Complement C1q, Complement C5, Factor B (C3 Proactivator), C1 (Esterase) Inhibitor.   

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/CLI_190902_doc_Image-SAA.jpg 440 720 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:47Serum Amyloid A (SAA), CE-IVD marked, turbidimetric assay

Ansh labs launches two new immunoassays for SARS-COV2

, 26 August 2020/in Corona News, Product News /by 3wmedia

Ansh labs has launched two new immunoassays, SARS-CoV2 IgG and IgM ELISAs, to assist in the fight against the Covid-19 pandemic.
Ansh Labs is releasing these two kits for sale in the United States under the provisions outlined in Section D of Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency. At the time of going to press, these tests were under review by the FDA for an Emergency Use Authorization.
IgM antibody is the first to be produced in response to viral proteins (antigens) and will be primarily detectable during the early onset of the disease. IgG antibodies are long-lasting and can persist in the bloodstream for many years after infection. This test has the advantage of detecting not only individuals with active infection (IgM), but also those who were previously exposed to the virus and may have subsequently developed immunity (IgG).
Testing for SARS-CoV2 antibodies can help in epidemiological surveillance about the spread of the virus and possible herd immunity. Ansh Labs’ SARS-CoV2 ELISAs are highly accurate with IgG ELISA offering 96% specificity and IgM ELISA offering 99% specificity.
For more information, visit: www.covid-diagnostics.com
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:31Ansh labs launches two new immunoassays for SARS-COV2
Page 148 of 152«‹146147148149150›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

March 2026

CLi Cover MRCH 2026
14 April 2026

Evident launches FV5000 confocal and multiphoton microscope

14 April 2026

Complex demands | Clear focus

17 March 2026

Complement assays for turbidimetry and nephelometry: C1q, C1 Inhibitor, C5 and Factor B

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription